Panasonic TOUGBOOK Showcases Mission-Ready Defence Solutions at DSEI 2025 ERYTECH Provides Business and Financial Update for the Third Quarter of 2021
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021 Conference call and…
Aligos Therapeutics to Present Virtually at the Jefferies London Healthcare Conference 2021
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
– Initiated a Phase 1/1b clinical trial for IVX-121, a virus like particle (VLP) vaccine…
Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., Nov. 15, 2021…
Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update
Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales…
Statera Biopharma Provides Third Quarter 2021 Financial and Corporate Update
Management to Host Conference Call Today, Monday, November 15, 2021, 5:30 p.m. ET FORT COLLINS,…
Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director
Veteran executive previously led Abbott’s global diagnostics organization Kim Popovits, interim chief executive officer, to…
CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update
Company to host conference call at 5:00 p.m. ET MENLO PARK, Calif., Nov. 15, 2021…
Fortress Biotech Reports Record Third Quarter 2021 Financial Results and Recent Corporate Highlights
Net revenue for third quarter of 2021 increased 123% year-over-year to $21.1 million, a quarterly…
Agios Appoints Richa Poddar as Chief Commercial Officer
Darrin Miles to Depart Agios to Pursue a Chief Executive Officer Opportunity CAMBRIDGE, Mass., Nov….
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company…
TFF Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
Positive Updates Announced for Inhaled Voriconazole and Tacrolimus Programs;Both Programs Advancing into Phase 2 Testing…
Surrozen Reports Third Quarter 2021 Financial Results
Product Candidates SZN-1326 and SZN-043 Advance Toward Initiation of Clinical Studies in 2022 Expanding and…
Valneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting
Saint–Herblain (France), November 15, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
NYMOX Presenting at Torrey Hills Capital Emerging Growth Conference
NYMOX Provides Current Update HASBROUCK HEIGHTS, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) — Nymox Pharmaceutical…
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Mechelen, Belgium; 15 November 2021; 16.45 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today…
The Consortium for Top-Down Proteomics Launches the Human Proteoform Project
New publication in Science Advances describes this ambitious initiative to define the chemical diversity of…
Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment
CALGARY, Alberta, Nov. 15, 2021 (GLOBE NEWSWIRE) — Zenith Capital Corp. (“Zenith” or the “Company”)…
Humacyte Presents New 12-Month Data from HAVs™ Produced Using Commercial-Scale Manufacturing System
– Performance of HAVs produced in the LUNA200™ commercial-scale system demonstrated efficacy that is similar to…
Transcontinental Advanced Coatings announces the launch of the Total Care Medical Product Portfolio
CHICAGO, Nov. 15, 2021 (GLOBE NEWSWIRE) — Transcontinental Advanced Coatings is thrilled to announce the…